746 related articles for article (PubMed ID: 15023377)
1. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
Abadie E; Ethgen D; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Nuki G; Van De Putte L; Vanhaelst L; Reginster JY;
Osteoarthritis Cartilage; 2004 Apr; 12(4):263-8. PubMed ID: 15023377
[TBL] [Abstract][Full Text] [Related]
2. Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.
Altman RD; Abadie E; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Menkes CJ; Pavelka K; Van De Putte L; Vanhaelst L; Reginster JY;
Osteoarthritis Cartilage; 2005 Jan; 13(1):13-9. PubMed ID: 15639632
[TBL] [Abstract][Full Text] [Related]
3. OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis.
Ornetti P; Brandt K; Hellio-Le Graverand MP; Hochberg M; Hunter DJ; Kloppenburg M; Lane N; Maillefert JF; Mazzuca SA; Spector T; Utard-Wlerick G; Vignon E; Dougados M
Osteoarthritis Cartilage; 2009 Jul; 17(7):856-63. PubMed ID: 19230857
[TBL] [Abstract][Full Text] [Related]
4. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group.
Conaghan PG; Hunter DJ; Maillefert JF; Reichmann WM; Losina E
Osteoarthritis Cartilage; 2011 May; 19(5):606-10. PubMed ID: 21396466
[TBL] [Abstract][Full Text] [Related]
5. Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014.
Eckstein F; Le Graverand MP
Semin Arthritis Rheum; 2015 Dec; 45(3):251-6. PubMed ID: 26142321
[TBL] [Abstract][Full Text] [Related]
6. How to define responders in osteoarthritis.
Cooper C; Adachi JD; Bardin T; Berenbaum F; Flamion B; Jonsson H; Kanis JA; Pelousse F; Lems WF; Pelletier JP; Martel-Pelletier J; Reiter S; Reginster JY; Rizzoli R; Bruyère O
Curr Med Res Opin; 2013 Jun; 29(6):719-29. PubMed ID: 23557069
[TBL] [Abstract][Full Text] [Related]
7. Association between hip and knee cartilage measured using radiographs and magnetic resonance imaging: the Tasmanian Older Adult Cohort Study.
Khan HI; Aitken D; Zhai G; Ding C; Pelletier JP; Pelletier JM; Cicuttini F; Blizzard L; Jones G
Rheumatology (Oxford); 2013 Nov; 52(11):2009-15. PubMed ID: 23901132
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
9. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.
Martel-Pelletier J; Roubille C; Abram F; Hochberg MC; Dorais M; Delorme P; Raynauld JP; Pelletier JP
Ann Rheum Dis; 2015 Mar; 74(3):547-56. PubMed ID: 24336337
[TBL] [Abstract][Full Text] [Related]
10. Is knee radiography useful for studying the efficacy of a disease-modifying osteoarthritis drug in humans?
Mazzuca SA; Brandt KD
Rheum Dis Clin North Am; 2003 Nov; 29(4):819-30. PubMed ID: 14603585
[TBL] [Abstract][Full Text] [Related]
11. Is the atrophic phenotype of tibiofemoral osteoarthritis associated with faster progression of disease? The MOST study.
Crema MD; Felson DT; Guermazi A; Nevitt MC; Niu J; Lynch JA; Marra MD; Torner J; Lewis CE; Roemer FW
Osteoarthritis Cartilage; 2017 Oct; 25(10):1647-1653. PubMed ID: 28606556
[TBL] [Abstract][Full Text] [Related]
12. Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis.
Emrani PS; Katz JN; Kessler CL; Reichmann WM; Wright EA; McAlindon TE; Losina E
Osteoarthritis Cartilage; 2008 Aug; 16(8):873-82. PubMed ID: 18280757
[TBL] [Abstract][Full Text] [Related]
13. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs.
Verbruggen G; Goemaere S; Veys EM
Clin Rheumatol; 2002 Jun; 21(3):231-43. PubMed ID: 12111630
[TBL] [Abstract][Full Text] [Related]
14. Hand joint space narrowing and osteophytes are associated with magnetic resonance imaging-defined knee cartilage thickness and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative.
Haugen IK; Cotofana S; Englund M; Kvien TK; Dreher D; Nevitt M; Lane NE; Eckstein F;
J Rheumatol; 2012 Jan; 39(1):161-6. PubMed ID: 22045837
[TBL] [Abstract][Full Text] [Related]
15. Rates and sensitivity of knee cartilage thickness loss in specific central reading radiographic strata from the osteoarthritis initiative.
Maschek S; Wirth W; Ladel C; Hellio Le Graverand MP; Eckstein F
Osteoarthritis Cartilage; 2014 Oct; 22(10):1550-3. PubMed ID: 25278063
[TBL] [Abstract][Full Text] [Related]
16. Progression of cartilage damage and meniscal pathology over 30 months is associated with an increase in radiographic tibiofemoral joint space narrowing in persons with knee OA--the MOST study.
Crema MD; Nevitt MC; Guermazi A; Felson DT; Wang K; Lynch JA; Marra MD; Torner J; Lewis CE; Roemer FW
Osteoarthritis Cartilage; 2014 Oct; 22(10):1743-7. PubMed ID: 25278083
[TBL] [Abstract][Full Text] [Related]
17. OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials.
Manno RL; Bingham CO; Paternotte S; Gossec L; Halhol H; Giacovelli G; Rovati L; Mazzuca SA; Clegg DO; Shi H; Tajana Messi E; Lanzarotti A; Dougados M
Osteoarthritis Cartilage; 2012 Feb; 20(2):93-101. PubMed ID: 22178465
[TBL] [Abstract][Full Text] [Related]
18. A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib.
Tindall EA; Sharp JT; Burr A; Katz TK; Wallemark CB; Verburg K; Lefkowith JB
Clin Ther; 2002 Dec; 24(12):2051-63. PubMed ID: 12581544
[TBL] [Abstract][Full Text] [Related]
19. Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography.
Hellio Le Graverand MP; Clemmer RS; Brunell RM; Hayes CW; Miller CG; Vignon E
Semin Arthritis Rheum; 2013 Aug; 43(1):1-8. PubMed ID: 23290692
[TBL] [Abstract][Full Text] [Related]
20. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
